Company overview
Novo Nordisk (or 'the company') is a leading global provider of diabetes products. The company also has a leadership position within areas such as hemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk primarily operates in Europe, North America and Japan. The company is headquartered in Bagsvaerd, Denmark, and employed 32,632 people as of December 31, 2011.
The company recorded revenues of DKK66,346 million ($12,400.1 million*) during the financial year ended December 2011 (FY2011), an increase of 9.2% over FY2010. The operating profit of the company was DKK22,374 million ($4,181.7 million*) in FY2011, an increase of 18.4% over FY2010. The net profit was DKK17,097 million ($3,195.4 million*) in FY2011, an increase of 18.7% over FY2010.
*Calculated using a constant conversion rate of DKK1 = $0.1869 for the financial year ended December 31, 2011.
Key facts
New York Stock Exchange ticker:
NVO
Copenhagen Stock Exchange ticker:
NVO B
No. employees: 32632
Turnover: 66,346,000,000 (DKK)
Financial year end: December
Summary
- Key facts
- Overview
- Business Description
- History
- Key Employees and Biographies
- Location and Subsidiaries
- Top Competitors
- Major Products and Services
SWOT Profiles
This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Scope of this research
- Provides all the crucial company information required for business and competitor intelligence needs.
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Key reasons to purchase this research
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available